ASH 2023 Hybrid Group Meetings

Saturday, December 9th to Monday, December 11th, Guidepoint Insights will be hosting a series of group meetings featuring KOLs who will dive deeper into (ASH) American Society of Hematology 2023 updates.

     
    Saturday, December 9th
    12:00 PM ET (9:00 AM PT) - Marc Braunstein // Hybrid
    • Multiple Myeloma | Clinical Assistant Professor of Medicine, NYU Langone Hospitals
    1:00 PM ET (10:00 AM PT) - Muhamed Baljevic // Hybrid
    • Multiple Myeloma, AML/MDS, Leukemia | Disease Team Lead of Plasma Cell Dyscrasias and Lymphomas, Vanderbilt University Medical Center
    2:00 PM ET (11:00 AM PT) - Kevin Kuo // Hybrid
    • Hemoglobinpathies | Associate Professor at Faculty of Medicine, University of Toronto
    2:00 PM ET (11:00 AM PT) - Jae Park // Hybrid
    • Novel CAR-Ts | Attending Physician, Memorial Sloan Kettering Cancer Center
    3:00 PM ET (12:00 PM PT) - Ravi Vij // Hybrid
    • Multiple Myeloma | Professor of Medicine in the Division of Medical Oncology at the Section of Bone Marrow Transplantation & Leukemia, Washington University School of Medicine
    3:00 PM ET (12:00 PM PT) - Abdulraheem Yacoub // Hybrid
    • Systemic Mastocytosis | Assistant Professor of Medicine, University of Kansas Medical Center
    4:00 PM ET (1:00 PM PT) - Douglas Tremblay // Hybrid
    • MPN (Myelofibrosis, PV, ET) | Physician and Assistant Professor, Mount Sinai Health System Inc.
    4:00 PM ET (1:00 PM PT) - Brad Hunter // Hybrid
    • Sickle Cell | Director of Immune Effector Cell Therapy and attending physician of Bone Marrow Transplant and Medical Oncology, Intermountain Health Care Inc.
    5:00 PM ET (2:00 PM PT) - Ben Samelson-Jones // Hybrid
    • Hemophilia | Assistant Professor of Pediatrics, University of Pennsylvania
    6:00 PM ET (3:00 PM PT) - Joshua Brody // Hybrid
    • Lymphoma | Associate Professor in Hematology and Medical Oncology & Director of the Lymphoma Immunotherapy Program, Mount Sinai Medical Center Inc.
    6:00 PM ET (3:00 PM PT) - Justin Kaner // Hybrid
    • Leukemia, AML/MDS | Assistant Professor, Weill Cornell Medicine
    7:00 PM ET (4:00 PM PT) - David Sallman // Hybrid
    • AML/MDS | Assistant Member, H. Lee Moffitt Cancer Center & Research Institute Inc.
    Sunday, December 10th
    12:00 PM ET (9:00 AM PT) - Ran Reshef // Hybrid
    • Novel CAR-Ts | Director of Translational Research and Blood and Marrow Transplantation Clinical Lead of CAR-T Cell Program and Associate Professor of Medicine, Columbia University Medical Center
    1:00 PM ET (10:00 AM PT) - Richard Drachtman // Hybrid
    • Sickle Cell | Clinical Section Chief of Pediatric Hematology/Oncology, Rutgers Cancer Institute of New Jersey
    1:00 PM ET (10:00 AM PT) - Rory Shallis // Hybrid
    • Leukemia, AML/MDS and MPN | Assistant Professor of Medicine (Hematology), Yale University School Of Medicine
    2:00 PM ET (11:00 AM PT) - Preet Chaudhary // Hybrid
    • Novel CAR-Ts | Founder, Angeles Therapeutics
    2:00 PM ET (11:00 AM PT) - Andrew Kuykendall // Hybrid
    • MPN (Myelofibrosis, PV, ET, Systemic Mastocystosis) | Assistant Professor, USF Health
    3:00 PM ET (12:00 PM PT) - Daniel DeAngelo // Hybrid
    • Leukemia, AML/MDS, MPN (Systemic Mastocytosis) | Professor of Medicine, Harvard Medical School
    3:00 PM ET (12:00 PM PT) - Joshua Sasine // Hybrid
    • Novel CAR-Ts | Assistant Professor of Medicine and Founder & Co-Director of the CAR-T Program at Cedars-Sinai Health System
    4:00 PM ET (1:00 PM PT) - Koichi Takahashi // Hybrid
    • Leukemias, AML/MDS | Hematologic Oncologist, University of Texas MD Anderson Cancer Center
    5:00 PM ET (2:00 PM PT) - Izidore Lossos // Hybrid
    • Lymphoma | Professor of Medicine, University of Miami
    5:00 PM ET (2:00 PM PT) - William Matsui // Hybrid
    • Hematologic Malignancy | Deputy Director, Livestrong Foundation Inc.
    6:00 PM ET (3:00 PM PT) - Andrew Branagan // Hybrid
    • Multiple Myeloma | Attending Physician, The General Hospital Corporation
    Monday, December 11th
    12:00 PM ET (9:00 AM PT) - Prithviraj Bose // Hybrid
    • MPN (Myelofibrosis, PV, ET, Systemic Mastocytosis) | Professor, MD Anderson Cancer Center Cooper
    12:00 PM ET (9:00 AM PT) - Nirmish Shah // Hybrid
    • Sickle Cell | Assistant Professor of Medicine and Pediatrics, Duke University
    1:00 PM ET (10:00 AM PT) - Sherif Badawy // Hybrid
    • Non-Malignant Hematology | Associate Professor of the Department of Pediatrics, Northwestern University Feinberg School of Medicine
    1:00 PM ET (10:00 AM PT) - Matthew Matasar // Hybrid
    • Multiple Myeloma, Lymphoma | Division Chief for Blood Disorders and Professor of Medicine, Rutgers Cancer Institute of New Jersey
    2:00 PM ET (11:00 AM PT) - Ashwin Kishtagari // Hybrid
    • MPN (Myelofibrosis, PV, ET), AML/MDS | Assistant Professor of Medicine, Vanderbilt University
    2:00 PM ET (11:00 AM PT) - Julie Kanter-Washko // Hybrid
    • Associate Professor & Director of Sickle Cell Disease Program, University of Alabama at Birmingham
    3:00 PM ET (12:00 PM PT) - Ryan Jacobs // Hybrid
    • CLL, Lymphoma | MD/Principle Investigator, Levine Cancer Institute
    4:00 PM ET (1:00 PM PT) - Uwe Platzbecker // Hybrid
    • Leukemias, AML/MDS | Director Hematology and Cellular Therapy, Universität Leipzig
    4:00 PM ET (1:00 PM PT) - Matthew Frigault // Hybrid
    • Novel CAR-Ts | Assistant Professor, Harvard Medical School
    5:00 PM ET (2:00 PM PT) - Saurabh Dahiya // Hybrid
    • Myeloma & Lymphoma | Associate Professor of Medicine and Clinical Director of Cancer Cell Therapy, Stanford University
    5:00 PM ET (2:00 PM PT) - Sagar Patel // Hybrid
    • Leukemias, Lymphomas, GvHD, Myelofibrosis, MPNs | Assistant Professor, Huntsman Cancer Institute University of Utah Health

    *ASH Group Meetings will be 50 minutes long and available only to attendees. Group meetings are not recorded and transcripts will not be available following the event.